Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
25 participants
INTERVENTIONAL
2018-08-01
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study VIP who are interested in purchasing a MED will be recruited and trained. The effectiveness of this training will be determined by assessing the usage of devices by the participants from completion of training to 6 months, using questionnaires, and by remote monitoring of their MED. Validated questionnaires will be used to measure changes in quality of life, depression, adaptation to vision loss, and ability to carry out everyday tasks, before and after training, and 6 months later. Ongoing support has been found to be important when introducing users to new technology, in the form of volunteers to provide assistance and advice. The standard "training course only" model will therefore be compared to a scheme in which each participant is paired with a "buddy" (a university student) who can provide continuing support by visiting the VIP regularly at home.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study aim is to evaluate the effectiveness of two different models of training in giving the user on-going access and improved quality of life. The two models to be compared will be a "training course only", versus a scheme in which each participant is paired with a "buddy" (a local university student) who can provide continuing assistance by visiting the participant at home.
VIP who are interested in purchasing a MED will be recruited and trained. The usage of devices will be assessed by questionnaire from completion of training to 6 months and through a tracking app. Validated questionnaires will be used to measure changes in quality of life, depression, adaptation to vision loss, and ability to carry out everyday tasks, before and after training, and 6 months later.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Using MED assigned buddy
Participant has been randomly assigned a student volunteer buddy, and has chosen to purchase an MED following training
MED
Training in the use of mainstream electronic devices with accessibility options
Buddy
A buddy who will meet with the participant regularly for social interaction, and assistance with use of any MED purchased
Using MED training only
Participant has been randomly assigned to not have a student volunteer buddy, and has chosen to purchase an MED following training
MED
Training in the use of mainstream electronic devices with accessibility options
No MED, assigned buddy
Participant has been randomly assigned a student volunteer buddy, and has chosen not to purchase an MED following training
Buddy
A buddy who will meet with the participant regularly for social interaction, and assistance with use of any MED purchased
No MED, no buddy
Participant has been randomly assigned to not have a student volunteer buddy, and has chosen not to purchase an MED following training
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MED
Training in the use of mainstream electronic devices with accessibility options
Buddy
A buddy who will meet with the participant regularly for social interaction, and assistance with use of any MED purchased
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* OR After evaluation it appears that MED would meet some/all requirements
* Willing to delay involvement in other forms of training or befriending for 6 months
* Has some form vision - does not rely exclusively on other senses
* Willing to travel for training/evaluation/meeting with buddy
* Agree not to seek additional formal/organised MED training elsewhere during the study
* Willing to fund any required MED personally
* Habitual language English
* 6 item Cognitive Impairment Test score 7 or lower
* Best corrected visual acuity logMAR 0.5 - 1.6 and/or log contrast sensitivity \<1.2
Exclusion Criteria
* Will be undergoing other MED/general computer training at the same time
* Will be actively enrolled in a new befriending/social group
* Already knows basics of MED and wants training on advanced skills
* Obvious cognitive impairment or uncorrected hearing loss such that communication is through a third party
* If updated Rx would improve VA by 2 lines or more, participant should be recommended to seek eye exam and then be re-evaluated 1 month later
* Visual condition likely to be treated/improved within study period such that MED no longer required
19 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
City, University of London
OTHER
Schepens Eye Research Institute
OTHER
University of Manchester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chris Dickinson
Professor of Clinical Optometry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chris Dickinson
Role: PRINCIPAL_INVESTIGATOR
University of Manchester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City University of London
London, , United Kingdom
University of Manchester
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5049/5050
Identifier Type: -
Identifier Source: org_study_id